 | • レポートコード：MRC2-11QY14471 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は緑膿菌肺炎治療薬のグローバル市場について調査・分析したレポートです。種類別（アエルシン、EV-035、MEDI-3902、パノバクマブ、その他）市場規模、用途別（病院、診療所、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別緑膿菌肺炎治療薬の競争状況、市場シェア ・世界の緑膿菌肺炎治療薬市場：種類別市場規模 2015年-2020年（アエルシン、EV-035、MEDI-3902、パノバクマブ、その他） ・世界の緑膿菌肺炎治療薬市場：種類別市場規模予測 2021年-2026年（アエルシン、EV-035、MEDI-3902、パノバクマブ、その他） ・世界の緑膿菌肺炎治療薬市場：用途別市場規模 2015年-2020年（病院、診療所、その他） ・世界の緑膿菌肺炎治療薬市場：用途別市場規模予測 2021年-2026年（病院、診療所、その他） ・北米の緑膿菌肺炎治療薬市場分析：米国、カナダ ・ヨーロッパの緑膿菌肺炎治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの緑膿菌肺炎治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の緑膿菌肺炎治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの緑膿菌肺炎治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Aridis Pharmaceuticals LLC、Emergent BioSolutions Inc、MedImmune LLC、Polyphor Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Pseudomonas Aeruginosa Pneumonia Drug Market
The global Pseudomonas Aeruginosa Pneumonia Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Pseudomonas Aeruginosa Pneumonia Drug Scope and Market Size
Pseudomonas Aeruginosa Pneumonia Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pseudomonas Aeruginosa Pneumonia Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Pseudomonas Aeruginosa Pneumonia Drug market is segmented into
Aerucin
EV-035
MEDI-3902
Panobacumab
Others
Segment by Application, the Pseudomonas Aeruginosa Pneumonia Drug market is segmented into
Hospital
Clinic
Others
Regional and Country-level Analysis
The Pseudomonas Aeruginosa Pneumonia Drug market is analysed and market size information is provided by regions (countries).
The key regions covered in the Pseudomonas Aeruginosa Pneumonia Drug market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Pseudomonas Aeruginosa Pneumonia Drug Market Share Analysis
Pseudomonas Aeruginosa Pneumonia Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Pseudomonas Aeruginosa Pneumonia Drug business, the date to enter into the Pseudomonas Aeruginosa Pneumonia Drug market, Pseudomonas Aeruginosa Pneumonia Drug product introduction, recent developments, etc.
The major vendors covered:
Aridis Pharmaceuticals LLC
Emergent BioSolutions Inc
MedImmune LLC
Polyphor Ltd
…
1 Study Coverage
1.1 Pseudomonas Aeruginosa Pneumonia Drug Product Introduction
1.2 Market Segments
1.3 Key Pseudomonas Aeruginosa Pneumonia Drug Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate by Type
1.4.2 Aerucin
1.4.3 EV-035
1.4.4 MEDI-3902
1.4.5 Panobacumab
1.4.6 Others
1.5 Market by Application
1.5.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size, Estimates and Forecasts
2.1.1 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue 2015-2026
2.1.2 Global Pseudomonas Aeruginosa Pneumonia Drug Sales 2015-2026
2.2 Global Pseudomonas Aeruginosa Pneumonia Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Pseudomonas Aeruginosa Pneumonia Drug Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Pseudomonas Aeruginosa Pneumonia Drug Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Pseudomonas Aeruginosa Pneumonia Drug Competitor Landscape by Players
3.1 Pseudomonas Aeruginosa Pneumonia Drug Sales by Manufacturers
3.1.1 Pseudomonas Aeruginosa Pneumonia Drug Sales by Manufacturers (2015-2020)
3.1.2 Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Manufacturers (2015-2020)
3.2 Pseudomonas Aeruginosa Pneumonia Drug Revenue by Manufacturers
3.2.1 Pseudomonas Aeruginosa Pneumonia Drug Revenue by Manufacturers (2015-2020)
3.2.2 Pseudomonas Aeruginosa Pneumonia Drug Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Pseudomonas Aeruginosa Pneumonia Drug Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Pseudomonas Aeruginosa Pneumonia Drug Revenue in 2019
3.2.5 Global Pseudomonas Aeruginosa Pneumonia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Pseudomonas Aeruginosa Pneumonia Drug Price by Manufacturers
3.4 Pseudomonas Aeruginosa Pneumonia Drug Manufacturing Base Distribution, Product Types
3.4.1 Pseudomonas Aeruginosa Pneumonia Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pseudomonas Aeruginosa Pneumonia Drug Product Type
3.4.3 Date of International Manufacturers Enter into Pseudomonas Aeruginosa Pneumonia Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size by Type (2015-2020)
4.1.1 Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2015-2020)
4.1.2 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Type (2015-2020)
4.1.3 Pseudomonas Aeruginosa Pneumonia Drug Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Type (2021-2026)
4.2.1 Global Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast by Type (2021-2026)
4.2.3 Pseudomonas Aeruginosa Pneumonia Drug Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Pseudomonas Aeruginosa Pneumonia Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Pseudomonas Aeruginosa Pneumonia Drug Market Size by Application (2015-2020)
5.1.1 Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2015-2020)
5.1.2 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Application (2015-2020)
5.1.3 Pseudomonas Aeruginosa Pneumonia Drug Price by Application (2015-2020)
5.2 Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Application (2021-2026)
5.2.1 Global Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Pseudomonas Aeruginosa Pneumonia Drug Price Forecast by Application (2021-2026)
6 North America
6.1 North America Pseudomonas Aeruginosa Pneumonia Drug by Country
6.1.1 North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country
6.1.2 North America Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Pseudomonas Aeruginosa Pneumonia Drug Market Facts & Figures by Type
6.3 North America Pseudomonas Aeruginosa Pneumonia Drug Market Facts & Figures by Application
7 Europe
7.1 Europe Pseudomonas Aeruginosa Pneumonia Drug by Country
7.1.1 Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Country
7.1.2 Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pseudomonas Aeruginosa Pneumonia Drug Market Facts & Figures by Type
7.3 Europe Pseudomonas Aeruginosa Pneumonia Drug Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug by Region
8.1.1 Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Region
8.1.2 Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Facts & Figures by Type
8.3 Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Facts & Figures by Application
9 Latin America
9.1 Latin America Pseudomonas Aeruginosa Pneumonia Drug by Country
9.1.1 Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country
9.1.2 Latin America Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Pseudomonas Aeruginosa Pneumonia Drug Market Facts & Figures by Type
9.3 Central & South America Pseudomonas Aeruginosa Pneumonia Drug Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug by Country
10.1.1 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Country
10.1.2 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Facts & Figures by Type
10.3 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Facts & Figures by Application
11 Company Profiles
11.1 Aridis Pharmaceuticals LLC
11.1.1 Aridis Pharmaceuticals LLC Corporation Information
11.1.2 Aridis Pharmaceuticals LLC Description and Business Overview
11.1.3 Aridis Pharmaceuticals LLC Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Products Offered
11.1.5 Aridis Pharmaceuticals LLC Related Developments
11.2 Emergent BioSolutions Inc
11.2.1 Emergent BioSolutions Inc Corporation Information
11.2.2 Emergent BioSolutions Inc Description and Business Overview
11.2.3 Emergent BioSolutions Inc Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Products Offered
11.2.5 Emergent BioSolutions Inc Related Developments
11.3 MedImmune LLC
11.3.1 MedImmune LLC Corporation Information
11.3.2 MedImmune LLC Description and Business Overview
11.3.3 MedImmune LLC Sales, Revenue and Gross Margin (2015-2020)
11.3.4 MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Products Offered
11.3.5 MedImmune LLC Related Developments
11.4 Polyphor Ltd
11.4.1 Polyphor Ltd Corporation Information
11.4.2 Polyphor Ltd Description and Business Overview
11.4.3 Polyphor Ltd Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Products Offered
11.4.5 Polyphor Ltd Related Developments
11.1 Aridis Pharmaceuticals LLC
11.1.1 Aridis Pharmaceuticals LLC Corporation Information
11.1.2 Aridis Pharmaceuticals LLC Description and Business Overview
11.1.3 Aridis Pharmaceuticals LLC Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Products Offered
11.1.5 Aridis Pharmaceuticals LLC Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Pseudomonas Aeruginosa Pneumonia Drug Market Estimates and Projections by Region
12.1.1 Global Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Regions 2021-2026
12.1.2 Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast by Regions 2021-2026
12.2 North America Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast (2021-2026)
12.2.1 North America: Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast (2021-2026)
12.2.2 North America: Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast (2021-2026)
12.2.3 North America: Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2021-2026)
12.3 Europe Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast (2021-2026)
12.3.1 Europe: Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast (2021-2026)
12.3.2 Europe: Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast (2021-2026)
12.3.3 Europe: Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Region (2021-2026)
12.5 Latin America Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast (2021-2026)
12.5.1 Latin America: Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast (2021-2026)
12.5.2 Latin America: Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast (2021-2026)
12.5.3 Latin America: Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Pseudomonas Aeruginosa Pneumonia Drug Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Pseudomonas Aeruginosa Pneumonia Drug Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pseudomonas Aeruginosa Pneumonia Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Pseudomonas Aeruginosa Pneumonia Drug Market Segments
Table 2. Ranking of Global Top Pseudomonas Aeruginosa Pneumonia Drug Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Aerucin
Table 5. Major Manufacturers of EV-035
Table 6. Major Manufacturers of MEDI-3902
Table 7. Major Manufacturers of Panobacumab
Table 8. Major Manufacturers of Others
Table 9. Global Pseudomonas Aeruginosa Pneumonia Drug Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Pseudomonas Aeruginosa Pneumonia Drug Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Regions (2015-2020)
Table 13. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Manufacturers (2015-2020)
Table 16. Global Pseudomonas Aeruginosa Pneumonia Drug Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Pseudomonas Aeruginosa Pneumonia Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pseudomonas Aeruginosa Pneumonia Drug as of 2019)
Table 18. Pseudomonas Aeruginosa Pneumonia Drug Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Pseudomonas Aeruginosa Pneumonia Drug Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Pseudomonas Aeruginosa Pneumonia Drug Price (2015-2020) (USD/Pcs)
Table 21. Pseudomonas Aeruginosa Pneumonia Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Pseudomonas Aeruginosa Pneumonia Drug Product Type
Table 23. Date of International Manufacturers Enter into Pseudomonas Aeruginosa Pneumonia Drug Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2015-2020) (K Pcs)
Table 26. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Type (2015-2020)
Table 27. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Share by Type (2015-2020)
Table 29. Pseudomonas Aeruginosa Pneumonia Drug Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2015-2020) (K Pcs)
Table 31. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Application (2015-2020)
Table 32. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2015-2020) (K Pcs)
Table 33. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2015-2020)
Table 34. North America Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Country (2015-2020)
Table 36. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2015-2020) (K Pcs)
Table 37. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type (2015-2020)
Table 38. North America Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2015-2020) (K Pcs)
Table 39. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2015-2020)
Table 40. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2015-2020)
Table 42. Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Country (2015-2020)
Table 44. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type (2015-2020)
Table 46. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2015-2020)
Table 56. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Country (2015-2020)
Table 60. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type (2015-2020)
Table 62. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2015-2020)
Table 72. Aridis Pharmaceuticals LLC Corporation Information
Table 73. Aridis Pharmaceuticals LLC Description and Major Businesses
Table 74. Aridis Pharmaceuticals LLC Pseudomonas Aeruginosa Pneumonia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Aridis Pharmaceuticals LLC Product
Table 76. Aridis Pharmaceuticals LLC Recent Development
Table 77. Emergent BioSolutions Inc Corporation Information
Table 78. Emergent BioSolutions Inc Description and Major Businesses
Table 79. Emergent BioSolutions Inc Pseudomonas Aeruginosa Pneumonia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Emergent BioSolutions Inc Product
Table 81. Emergent BioSolutions Inc Recent Development
Table 82. MedImmune LLC Corporation Information
Table 83. MedImmune LLC Description and Major Businesses
Table 84. MedImmune LLC Pseudomonas Aeruginosa Pneumonia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. MedImmune LLC Product
Table 86. MedImmune LLC Recent Development
Table 87. Polyphor Ltd Corporation Information
Table 88. Polyphor Ltd Description and Major Businesses
Table 89. Polyphor Ltd Pseudomonas Aeruginosa Pneumonia Drug Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. Polyphor Ltd Product
Table 91. Polyphor Ltd Recent Development
Table 92. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Regions (2021-2026) (K Pcs)
Table 93. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share Forecast by Regions (2021-2026)
Table 94. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 95. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share Forecast by Regions (2021-2026)
Table 96. North America: Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 97. North America: Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 98. Europe: Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 99. Europe: Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 100. Asia Pacific: Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Region (2021-2026) (K Pcs)
Table 101. Asia Pacific: Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast by Region (2021-2026) (US$ Million)
Table 102. Latin America: Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 103. Latin America: Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 104. Middle East and Africa: Pseudomonas Aeruginosa Pneumonia Drug Sales Forecast by Country (2021-2026) (K Pcs)
Table 105. Middle East and Africa: Pseudomonas Aeruginosa Pneumonia Drug Revenue Forecast by Country (2021-2026) (US$ Million)
Table 106. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 107. Key Challenges
Table 108. Market Risks
Table 109. Main Points Interviewed from Key Pseudomonas Aeruginosa Pneumonia Drug Players
Table 110. Pseudomonas Aeruginosa Pneumonia Drug Customers List
Table 111. Pseudomonas Aeruginosa Pneumonia Drug Distributors List
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Pseudomonas Aeruginosa Pneumonia Drug Product Picture
Figure 2. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Aerucin Product Picture
Figure 4. EV-035 Product Picture
Figure 5. MEDI-3902 Product Picture
Figure 6. Panobacumab Product Picture
Figure 7. Others Product Picture
Figure 8. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application in 2020 & 2026
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Others
Figure 12. Pseudomonas Aeruginosa Pneumonia Drug Report Years Considered
Figure 13. Global Pseudomonas Aeruginosa Pneumonia Drug Market Size 2015-2026 (US$ Million)
Figure 14. Global Pseudomonas Aeruginosa Pneumonia Drug Sales 2015-2026 (K Pcs)
Figure 15. Global Pseudomonas Aeruginosa Pneumonia Drug Market Size Market Share by Region: 2020 Versus 2026
Figure 16. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Region (2015-2020)
Figure 17. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Region in 2019
Figure 18. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Region (2015-2020)
Figure 19. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Region in 2019
Figure 20. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Share by Manufacturer in 2019
Figure 21. The Top 10 and 5 Players Market Share by Pseudomonas Aeruginosa Pneumonia Drug Revenue in 2019
Figure 22. Pseudomonas Aeruginosa Pneumonia Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type (2015-2020)
Figure 24. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Type in 2019
Figure 25. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Type (2015-2020)
Figure 26. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Type in 2019
Figure 27. Global Pseudomonas Aeruginosa Pneumonia Drug Market Share by Price Range (2015-2020)
Figure 28. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application (2015-2020)
Figure 29. Global Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Application in 2019
Figure 30. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Application (2015-2020)
Figure 31. Global Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Application in 2019
Figure 32. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 33. North America Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 34. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country in 2019
Figure 35. North America Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Country in 2019
Figure 36. U.S. Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 37. U.S. Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Canada Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. Canada Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. North America Pseudomonas Aeruginosa Pneumonia Drug Market Share by Type in 2019
Figure 41. North America Pseudomonas Aeruginosa Pneumonia Drug Market Share by Application in 2019
Figure 42. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 43. Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 44. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country in 2019
Figure 45. Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Country in 2019
Figure 46. Germany Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 47. Germany Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. France Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. France Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. U.K. Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. U.K. Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Italy Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. Italy Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Russia Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Russia Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Europe Pseudomonas Aeruginosa Pneumonia Drug Market Share by Type in 2019
Figure 57. Europe Pseudomonas Aeruginosa Pneumonia Drug Market Share by Application in 2019
Figure 58. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 59. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 60. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Region in 2019
Figure 61. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Region in 2019
Figure 62. China Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 63. China Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. Japan Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. Japan Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. South Korea Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. South Korea Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. India Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. India Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Australia Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. Australia Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Taiwan Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Taiwan Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Indonesia Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Indonesia Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Thailand Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Thailand Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Malaysia Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Malaysia Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Philippines Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Philippines Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Vietnam Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Vietnam Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Share by Type in 2019
Figure 85. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Market Share by Application in 2019
Figure 86. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 87. Latin America Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 88. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country in 2019
Figure 89. Latin America Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Country in 2019
Figure 90. Mexico Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 91. Mexico Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Brazil Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Brazil Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Argentina Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Argentina Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Latin America Pseudomonas Aeruginosa Pneumonia Drug Market Share by Type in 2019
Figure 97. Latin America Pseudomonas Aeruginosa Pneumonia Drug Market Share by Application in 2019
Figure 98. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate 2015-2020 (K Pcs)
Figure 99. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate 2015-2020 (US$ Million)
Figure 100. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Market Share by Country in 2019
Figure 101. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue Market Share by Country in 2019
Figure 102. Turkey Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 103. Turkey Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Saudi Arabia Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Saudi Arabia Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. U.A.E Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. U.A.E Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Share by Type in 2019
Figure 109. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Market Share by Application in 2019
Figure 110. North America Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 111. North America Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Europe Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. Europe Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Asia Pacific Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Latin America Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Latin America Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Middle East and Africa Pseudomonas Aeruginosa Pneumonia Drug Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Porter's Five Forces Analysis
Figure 121. Channels of Distribution
Figure 122. Distributors Profiles
Figure 123. Bottom-up and Top-down Approaches for This Report
Figure 124. Data Triangulation
Figure 125. Key Executives Interviewed
耐性緑膿菌感染症治療薬の世界市場（～2026年） Market Analysis and Insights: Global Resistant Pseudomonas Aeruginosa Infections Drugs Market The global Resistant Pseudomonas Aeruginosa Infections Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Resistant Pseud…- 院内肺炎予防の世界市場（～2026年） HAP is defined as a lower respiratory infection, which does not incubate at the time of hospital admission but presents clinically 2 or more days after hospitalization.Incidence of HAP is more prevalent in the medical and surgical Intensive Care Units, and results in additional cost to the healthcar…
- 肺炎の世界市場（～2026年） Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affec…
- シュードモナス診断検査の世界市場（～2026年） Pseudomonas is a genus of Gram-negative, Gammaproteobacteria, belonging to the family Pseudomonadaceae and containing 191 validly described species. The global pseudomonas diagnostic testing market is expected to grow rapidly over the forecast period owing to the advanced application of bacterial di…
- 肺炎治療薬の世界市場（～2026年） Pneumonia is a respiratory disease characterized by inflammation of air sacs in lungs due to bacterial or viral infection. The emergence of advanced diagnostic techniques to be one of the primary factors fueling the growth of the pneumonia therapeutics market in the coming years. Market Analysis and…